Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OPICAPONE vs ORELABRUTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OPICAPONE vs ORELABRUTINIB: Safety Overview

Metric OPICAPONE ORELABRUTINIB
Total FAERS Reports 1,090 131
Deaths Reported 80 29
Death Rate 7.3% 22.1%
Hospitalizations 305 12
Average Patient Age 70.6 yrs 66.0 yrs
% Female Patients 42.2% 63.8%
FDA Approval Date Apr 24, 2020 N/A
Manufacturer Amneal Pharmaceuticals LLC N/A
Route ORAL N/A
Marketing Status Prescription N/A